Bliss GVS Pharma Limited specializes in Pharmaceuticals within the Healthcare sector.
Bliss GVS Pharma Limited, with Security Code 506197, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Date Begin | Date End | Net Sales | Net Profit | Total Income | Diluted EPS for continuing operation | Other Expenses | Other Income | Depreciation and amortisation expense | Profit (+)/ Loss (-) from Ordinary Activities before Tax |
|---|---|---|---|---|---|---|---|---|---|
| 2024-01-01 | 2024-03-31 | 1,981.28 | -49.14 | 2,037.28 | -0.86 | - | 56.00 | -68.47 | -39.49 |
| 2024-01-01 | 2024-03-31 | 1,638.17 | -114.61 | 1,722.81 | -1.08 | -108.59 | 84.64 | -62.29 | -152.33 |
| 2023-10-01 | 2023-12-31 | 1,613.35 | 207.20 | 1,692.31 | 1.95 | -43.96 | 78.97 | -62.48 | 285.21 |
| 2023-10-01 | 2023-12-31 | 2,007.18 | 290.73 | 2,061.41 | 2.60 | - | 54.23 | -69.54 | 400.45 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 7% |
| 3 Years: | 9% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 0% |
| 3 Years: | 4% |
| TTM: | -11% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | -8% |
| 3 Years: | -2% |
| 1 Year: | 27% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | -3% |
| 3 Years: | 10% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | -6% |
| 3 Years: | 11% |
| TTM: | 33% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | -8% |
| 3 Years: | -2% |
| 1 Year: | 27% |
The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Levothyroxine Sodium tablets, the generic equivalent of Synthroid tablets of AbbVie Inc.
The company's revenue from operations rose to Rs 666.83 crore in the fourth quarter ended March 2023, as compared to Rs 562.28 crore in the same period last year.
The company has launched a branded generic version of Zolpidem Tartrate, a prescription sleep medication, under the brand name 'Zolsana'.
